Basophil Recruitment into Tumor-Draining Lymph Nodes Correlates with Th2 Inflammation and Reduced Survival in Pancreatic Cancer Patients.
暂无分享,去创建一个
M. Reni | M. Falconi | A. Paganoni | C. Doglioni | A. Mondino | H. Algül | M. P. Protti | G. Balzano | S. Heltai | H. Recalde | S. Wörmann | L. De Monte | F. Aleotti | Emanuela Brunetto | G. Magliacane | M. Protti | Gilda Magliacane | L. D. De Monte
[1] J. Schroeder,et al. IL‐3 synergises with basophil‐derived IL‐4 and IL‐13 to promote the alternative activation of human monocytes , 2015, European journal of immunology.
[2] A. Sperling,et al. Distinct dendritic cell subsets actively induce Th2 polarization. , 2014, Current opinion in immunology.
[3] Christian Veltkamp,et al. A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer , 2014, Nature Medicine.
[4] M. Lesina,et al. The immune network in pancreatic cancer development and progression , 2014, Oncogene.
[5] V. Soumelis,et al. Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade , 2013, Nature Communications.
[6] L. De Monte,et al. Immune infiltrates as predictive markers of survival in pancreatic cancer patients , 2013, Front. Physiol..
[7] C. Garlanda,et al. Tumor associated macrophages and neutrophils in tumor progression , 2013, Journal of cellular physiology.
[8] E. Jaffee,et al. Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma. , 2013, Gastroenterology.
[9] R. Vonderheide,et al. Inflammatory networks and immune surveillance of pancreatic carcinoma. , 2013, Current opinion in immunology.
[10] B. Vickery,et al. TSLP Promotes Interleukin-3-independent Basophil Haematopoiesis and Type 2 Inflammation , 2012, Pediatrics.
[11] Derek S. Chan,et al. The Pancreas Cancer Microenvironment , 2012, Clinical Cancer Research.
[12] Alexander A. Fingerle,et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications , 2012, Nature Reviews Gastroenterology &Hepatology.
[13] M. P. Protti,et al. Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer , 2012, Oncoimmunology.
[14] P. Hwu,et al. Mast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal Adenocarcinoma , 2011, Clinical Cancer Research.
[15] K. Pan,et al. Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma. , 2011, Surgery.
[16] H. Karasuyama,et al. Nonredundant roles of basophils in immunity. , 2011, Annual review of immunology.
[17] M. Braga,et al. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer , 2011, The Journal of experimental medicine.
[18] D. Artis,et al. New insights into basophil biology: initiators, regulators, and effectors of type 2 inflammation , 2011, Annals of the New York Academy of Sciences.
[19] D. Voehringer,et al. Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. , 2010, Immunity.
[20] T. Kepler,et al. The T helper type 2 response to cysteine proteases requires dendritic cell–basophil cooperation via ROS-mediated signaling , 2010, Nature Immunology.
[21] S. Dangi‐Garimella,et al. Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor Progression , 2010, Clinical Cancer Research.
[22] W. Paul,et al. How are TH2-type immune responses initiated and amplified? , 2010, Nature Reviews Immunology.
[23] E. Forbes,et al. Differential requirements for IL‐4/STAT6 signalling in CD4 T‐cell fate determination and Th2‐immune effector responses , 2010, Immunology and cell biology.
[24] P. Valent,et al. Role of interleukins in the regulation of basophil development and secretion , 2010, Current opinion in hematology.
[25] J. Schroeder,et al. Human Basophils Secrete IL-3: Evidence of Autocrine Priming for Phenotypic and Functional Responses in Allergic Disease1 , 2009, The Journal of Immunology.
[26] S. Pai,et al. GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation , 2009, Nature Reviews Immunology.
[27] M. Braga,et al. Carcinoembryonic Antigen-Specific but Not Antiviral CD4+ T Cell Immunity Is Impaired in Pancreatic Carcinoma Patients1 , 2008, The Journal of Immunology.
[28] W. Paul,et al. Basophils and type 2 immunity , 2008, Current opinion in hematology.
[29] Helmut Friess,et al. Pancreatic cancer microenvironment , 2007, International journal of cancer.
[30] R. Valenta,et al. Interleukin-3 Promotes the Expression of E-NPP3/CD203C on Human Blood Basophils in Healthy Subjects and in Patients with Birch Pollen Allergy , 2007, International journal of immunopathology and pharmacology.
[31] Tomoki Ito,et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. , 2007, Annual review of immunology.
[32] Friedrich Paulsen,et al. Ptf1a is essential for the differentiation of GABAergic and glycinergic amacrine cells and horizontal cells in the mouse retina , 2007, Development.
[33] E. Knol,et al. Diagnostic Tests Based on Human Basophils: Potentials, Pitfalls and Perspectives , 2006, International Archives of Allergy and Immunology.
[34] R. Mocharla,et al. Identification of basophils by a mAb directed against pro-major basic protein 1. , 2006, The Journal of allergy and clinical immunology.
[35] K. Ohta,et al. IgE- and FcεRI-mediated migration of human basophils , 2005 .
[36] M. Reni,et al. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial. , 2005, The Lancet. Oncology.
[37] N. Funel,et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma , 2004, Journal of Clinical Pathology.
[38] T. Jacks,et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.
[39] A. Berns,et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer , 2001, Nature Genetics.
[40] L. Hellman,et al. MMCP‐8, the first lineage‐specific differentiation marker for mouse basophils. Elevated numbers of potent IL‐4‐producing and MMCP‐8‐positive cells in spleens of malaria‐infected mice , 2000, European journal of immunology.
[41] D. V. Von Hoff,et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] Franco H Falcone,et al. Purified human peripheral blood basophils release interleukin‐13 and preformed interleukin‐4 following immunological activation , 1996, European journal of immunology.
[43] A. Minty,et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine , 1994, The Journal of experimental medicine.
[44] C. Heusser,et al. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation , 1993, The Journal of experimental medicine.
[45] E. Leonard,et al. Purification of Human Blood Basophils by Single Step Isopycnic Banding on Percoll , 1984, Journal of leukocyte biology.
[46] P J Kumar,et al. The Exocrine Pancreas. , 1980 .
[47] F. Granata,et al. Basophils: historical reflections and perspectives. , 2014, Chemical immunology and allergy.
[48] D. Artis,et al. Functional heterogeneity in the basophil cell lineage. , 2012, Advances in immunology.
[49] K. Ohta,et al. IgE- and FcepsilonRI-mediated migration of human basophils. , 2005, International immunology.
[50] Michael Sixt,et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. , 2005, Immunity.